Page last updated: 2024-08-23

sq-11725 and Cirrhosis, Liver

sq-11725 has been researched along with Cirrhosis, Liver in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (17.39)	18.7374
1990's	11 (23.91)	18.2507
2000's	20 (43.48)	29.6817
2010's	7 (15.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayes, P; Robertson, M	1
Bendtsen, F; Gluud, LL; Hobolth, L; Jeyaraj, R; Morgan, MY; Zacharias, AP	1
Advani, S; Cao, Y; El-Serag, HB; Kanwal, F; Kramer, J; Shukla, R; Tansel, A; Walder, A; Ying, J	1
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C	1
Alvarez-Urturi, C; Aracil, C; Balanzó, J; Colomo, A; Guarner, C; Hernández-Gea, V; López-Balaguer, JM; Torras, X; Villanueva, C	1
Altamirano, JT; Augustin, S; Esteban, R; Genescà, J; González, A; Guardia, J; Muntaner, L	1
Talwalkar, JA	1
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A	1
Gane, EJ; Lee, WG; McCall, JL; Murphy, R; Plank, LD	1
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S	1
Abecasis, R; Ameigeiras, B; Argonz, J; Dominguez, N; Fassio, E; Garcia, D; Isla, R; Kravetz, D; Landeira, G; Romero, G; Terg, R	1
Chen, MH; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CP; Lo, CC; Lo, GH	1
Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C	1
Bhaskar, ME	1
Mann, NS	1
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M	1
Bolognesi, M; Bombonato, G; Cavasin, L; Gatta, A; Merkel, C; Sacerdoti, D	1
Bosch, J	1
Andreone, P; Berzigotti, A; Magalotti, D; Morelli, MC; Rinaldi, MF; Rossi, C; Zappoli, P; Zoli, M	1
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C	1
Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Malagelada, JR; Pérez, M; Saperas, E; Segarra, A; Tomasello, A	1
Laleman, W; Nevens, F	1
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM	1
Bernardi, M; Berzigotti, A; Bracci, E; Caraceni, P; Di Micoli, A; Domenicali, M; Felline, P; Savelli, F; Trevisani, F; Zambruni, A; Zoli, M	1
Battaglia, G; Gatta, A; Merkel, C; Milani, L; Sacerdoti, D; Zuin, R	1
Amodio, P; Angeli, P; Cavallarin, G; Donada, C; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sebastianelli, G; Torboli, P	1
Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D	1
Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D	1
Dave, M; Langbart, MM	1
Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E	1
Angeli, P; Bolognesi, M; Bombonato, G; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sacerdoti, D	1
Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D	1
Amodio, P; Angeli, P; Bolognesi, M; Buonamico, P; Gatta, A; Merkel, C; Micotti, L; Sacerdoti, D; Sticca, A	1
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P	1
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D	1
Herrera, JL; Zalepuga, R	1
Elder, CA; Restino, MS	1
Calès, P; Ideo, G; Lebrec, D; Pagliaro, L; Pascal, JP; Pasta, L; Poynard, T	1
Gatta, A; Merkel, C; Sacerdoti, D	1
Benhamou, JP; Capron, JP; Chaput, JC; Geoffroy, P; Hillon, P; Lebrec, D; Poynard, T; Roulot, D; Rueff, B	1
Bolognesi, M; Caregaro, L; Finucci, GF; Gatta, A; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D	1
Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D; Zuin, R	1
Bolognesi, M; Borsato, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D	1
Angeli, P; Bolognesi, M; Finucci, GF; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D	1
Bazzerla, G; Bolognesi, M; Finucci, GF; Gatta, A; Merkel, C; Sacerdoti, D; Zuin, R	1
Bolognesi, M; Finucci, G; Gatta, A; Merkel, C; Rossoni, R; Sacerdoti, D; Zuin, R	1

Reviews

4 review(s) available for sq-11725 and Cirrhosis, Liver

Article	Year
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. The Cochrane database of systematic reviews, 2018, Oct-29, Volume: 10 Topics: Adrenergic beta-Antagonists; Adult; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention	2018
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding. Minerva medica, 2006, Volume: 97, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents	2006
Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices. Clinical pharmacy, 1992, Volume: 11, Issue:4 Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propranolol	1992
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter The New England journal of medicine, 1991, May-30, Volume: 324, Issue:22 Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol	1991

Trials

26 trial(s) available for sq-11725 and Cirrhosis, Liver

Article	Year
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Alimentary pharmacology & therapeutics, 2009, Feb-15, Volume: 29, Issue:4 Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure	2009
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology, 2009, Volume: 137, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Portal Pressure; Predictive Value of Tests; Proportional Hazards Models; Propranolol; Risk Assessment; ROC Curve; Time Factors; Treatment Outcome	2009
High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:8 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Regression Analysis; Temperance	2010
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:1 Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome	2012
Oral β-blockade in relation to energy expenditure in clinically stable patients with liver cirrhosis: a double-blind randomized cross-over trial. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:11 Topics: Administration, Oral; Adrenergic beta-Antagonists; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Placebos	2012
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. Journal of hepatology, 2002, Volume: 37, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents	2002
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Spironolactone; Splanchnic Circulation; Treatment Outcome	2003
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointestinal endoscopy, 2004, Volume: 59, Issue:3 Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Esophagoscopy; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Probability; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome	2004
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. Journal of hepatology, 2004, Volume: 40, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis	2004
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Digestive diseases and sciences, 2005, Volume: 50, Issue:8 Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents	2005
Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis? Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:1 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Biopsy; Disease Progression; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Nadolol; Single-Blind Method; Treatment Outcome	2005
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Alimentary pharmacology & therapeutics, 2006, Aug-15, Volume: 24, Issue:4 Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention	2006
Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study. Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:4 Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Hepatic Veins; Humans; Ligation; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Secondary Prevention; Venous Pressure	2006
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients. Journal of the Chinese Medical Association : JCMA, 2006, Volume: 69, Issue:10 Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol	2006
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. Journal of hepatology, 2008, Volume: 48, Issue:3 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Hepatic Veins; Humans; Liver Cirrhosis; Male; Middle Aged; Models, Biological; Nadolol; Prognosis; Risk Factors; Ventricular Function	2008
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale. Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Nadolol; Venous Pressure	1995
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis. Bildgebung = Imaging, 1995, Volume: 62, Issue:2 Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents	1995
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1994, Volume: 13, Issue:12 Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents	1994
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation? Transplantation proceedings, 1994, Volume: 26, Issue:6 Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors	1994
Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Hepatic Artery; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nadolol; Vasodilator Agents	1997
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. Journal of hepatology, 1998, Volume: 28, Issue:4 Topics: Adrenergic beta-Antagonists; Catheterization, Peripheral; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Linear Models; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents	1998
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:2 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic	2000
Should nitrates be used with beta blockers to prevent variceal bleeding? The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents	2000
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter The New England journal of medicine, 1991, May-30, Volume: 324, Issue:22 Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol	1991
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. Journal of hepatology, 1988, Volume: 7, Issue:1 Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Patient Compliance	1988
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. Digestion, 1987, Volume: 37, Issue:1 Topics: Adult; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Random Allocation; Recurrence	1987

Other Studies

17 other study(ies) available for sq-11725 and Cirrhosis, Liver

Article	Year
Primary prophylaxis of variceal bleeding. Hepatology international, 2018, Volume: 12, Issue:1 Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propanolamines; Propranolol	2018
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. The American journal of gastroenterology, 2016, Volume: 111, Issue:12 Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Ascites; Cohort Studies; Comorbidity; Dose-Response Relationship, Drug; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Primary Prevention; Proportional Hazards Models; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; United States; United States Department of Veterans Affairs	2016
Evening administration of long-acting beta-blockers for primary prophylaxis in cirrhosis: an effective strategy. The American journal of gastroenterology, 2011, Volume: 106, Issue:3 Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Treatment Outcome	2011
Management of cirrhosis and ascites. The New England journal of medicine, 2004, Jul-15, Volume: 351, Issue:3 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents	2004
Nadolol versus band ligation for prevention of variceal bleeding. Gastrointestinal endoscopy, 2004, Volume: 60, Issue:6 Topics: Adrenergic beta-Antagonists; Chronotherapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Nadolol; Randomized Controlled Trials as Topic; Treatment Outcome	2004
Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation. Alimentary pharmacology & therapeutics, 2005, Sep-01, Volume: 22, Issue:5 Topics: Acute Disease; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Chronic Disease; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome	2005
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. Journal of hepatology, 2006, Volume: 44, Issue:2 Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Disease Progression; Female; Follow-Up Studies; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Mesenteric Arteries; Middle Aged; Nadolol; Primary Prevention; Prospective Studies; Splanchnic Circulation; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasoconstriction	2006
Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. American heart journal, 1984, Volume: 108, Issue:4 Pt 2 Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Diuresis; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines; Renal Circulation	1984
Nadolol for lithium tremor in the presence of liver damage. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:1 Topics: Adult; Dose-Response Relationship, Drug; Humans; Lithium; Liver Cirrhosis; Liver Function Tests; Male; Nadolol; Neurocognitive Disorders; Psychotic Disorders; Tremor	1994
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:11 Topics: Adrenergic beta-Antagonists; Coloring Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Indocyanine Green; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nadolol; Nitric Oxide Donors; Venous Pressure	1999
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents	2000
Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis. Journal of hepatology, 1991, Volume: 12, Issue:1 Topics: Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Male; Nadolol; Time Factors	1991
Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis. European journal of clinical pharmacology, 1988, Volume: 34, Issue:5 Topics: Adult; Heart Rate; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Middle Aged; Nadolol	1988
Renal effects of nadolol in cirrhosis. European journal of clinical pharmacology, 1987, Volume: 33, Issue:5 Topics: Cardiac Output; Dinoprostone; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Nadolol; Prostaglandins E; Renin-Angiotensin System	1987
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. Clinical physiology (Oxford, England), 1987, Volume: 7, Issue:5 Topics: Adult; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation	1987
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. British journal of clinical pharmacology, 1986, Volume: 21, Issue:6 Topics: Adult; Antihypertensive Agents; Hepatic Veins; Humans; Hypertension, Portal; Liver; Liver Circulation; Liver Cirrhosis; Middle Aged; Nadolol; Propanolamines; Venous Pressure	1986
Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:6 Topics: Cardiac Output; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines	1985